SCHEMBL25051753

SCHEMBL25051753

O=C1OC(C(Cl)(Cl)Cl)N2CCCC12COCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 7/20 0.35
SLC6A4 P31645 5/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
CTSV O60911 1/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
CTSC P53634 1/20 0.34
CTSF Q9UBX1 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
PREP P48147 1/20 0.32
LIPE Q05469 1/20 0.32
OPRM1 P35372 1/20 0.32
KCNH2 Q12809 1/20 0.32
SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19614475 1.00 TACR1 (0.35) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL1057324 0.85 KMT2A (0.38) MEN1KMT2ASIGMAR1
SCHEMBL19627471 0.83 LMNA (0.36) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL19628503 0.83 LMNA (0.36) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL19627465 0.83 LMNA (0.36) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL15029188 0.82 MEN1 (0.34) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL2085683 0.74
SCHEMBL19629072 0.72 TACR1 (0.37) TACR1SLC6A4MEN1KMT2ALMNA
SCHEMBL1054202 0.71 L3MBTL1 (0.40) MEN1KMT2ALMNAOPRM1KCNH2
SCHEMBL31504154 0.67 CTSV (0.37) CTSVCTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083472-A2 PROTAC COMPOUNDS BINDING KEAP1 UBIQUITIN LIGASE FOR TARGETED PROTEIN DEGRADATION SEED THERAPEUTICS US, INC. (US) 2025-04-24 WO disclosed
WO-2023018699-A1 SELECTIVE KRAS INHIBITORS ERASCA, INC. (US) 2023-02-16 WO disclosed